The pursuit of a cure for Alzheimer's disease is becoming an increasingly competitive and contentious quest, with recent ...

Abnormal clumps of proteins like α-synuclein, amyloid beta and tau are associated with neurodegenerative conditions like Parkinson's and Alzheimer's disease, but a waste removal mechanism called the ...

Following the hard-won success of early anti-amyloid drugs, a new generation of Alzheimer’s modalities—from tau-targeting ...

Scientists have shown that a non-invasive sound stimulation of the brain at a specific frequency can clear toxic proteins ...

The trial seeks to find an easier and less expensive way to detect a disease that affects 1 in 9 people over the age of 65.

For more than a century, Alzheimer’s disease has been framed as a slow catastrophe that begins inside the brain and stays ...

Researchers at Wakayama Medical University in Japan have discovered that amyloid-β deposits disrupt the formation of the ...

Rates of amyloid build-up in the brain accelerate and then decelerate before reaching a plateau, providing a possible 15-year window of opportunity for intervention to prevent Alzheimer's disease (AD) ...

Novartis’ continuing search for new ways to take drugs into the brain has resulted in a $1.7 billion deal with SciNeuro ...

Researchers from the University of Turku and Åbo Akademi University in Finland and the University of Wisconsin in the United States demonstrated that individuals who had childhood epilepsy have an ...